Drug resistance is an unsolved and major concern in the bacterial infection. Continuous
development of drug-resistance to the antibiotics exponentially rises the danger of bacterial …

Introduction Antibacterial drugs have been widely used for the past century to treat diseases,
but their efficacy has been limited by multi-resistant pathogens, particularly those that utilize …

Introduction This study aimed to evaluate new Staphylococcus aureus β-lactamase
inhibitors from medicinal plants Rosmarinus officinalis, Ocimum basilicum, Eucalyptus …

Abstract Stenotrophomonas maltophilia, a Multiple-Drug-Resistant proteobacterium found in
healthy normal flora and fauna with an aerobic and non-fermentative respiratory process, is …

The β-lactamase of Pseudomonas aeruginosa is known to degrade β-lactam antibiotics
such as penicillins, cephalosporins, monobactams, and carbapenems. With the discovery of …

Methicillin-resistant Staphylococcus aureus (MRSA) is a life-threatening superbug causing
infectious diseases such as pneumonia, endocarditis, osteomyelitis, etc. Conventional …

Antibiotic resistance is threatening the medical industry in treating microbial infections. Many
organisms are acquiring antibiotic resistance because of the continuous use of the same …

Abstract β-lactamase are the main resistance factor for β-lactam antibiotics in Gram-negative
bacteria. Since β-lactam antibiotics are being utilised as an antimicrobial agents extensively …

New Delhi metallo-β-lactamase (NDM-1) is the most recent addition to the class of metallo-β-
lactamases (MBLs). This enzyme leads to antibiotic resistance in clinical treatments owing to …

New Delhi metallo-β-lactamase variants and different types of metallo-β-lactamases have
attracted enormous consideration for hydrolyzing almost all β-lactam antibiotics, which leads …